Phase 2 Clinical Trial of Attenuated Salmonella enterica Serovar Typhi Oral Live Vector Vaccine CVD 908-htrA in U.S. Volunteers

Salmonella enterica serovar Typhi strain CVD 908-htrA is a live attenuated strain which may be useful as an improved oral typhoid vaccine and as a vector for cloned genes of other pathogens. We conducted a phase 2 trial in which 80 healthy adults received one of two dosage levels of CVD 908-htrA in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Tacket, Carol O., Sztein, Marcelo B., Wasserman, Steven S., Losonsky, Genevieve, Kotloff, Karen L., Wyant, Timothy L., Nataro, James P., Edelman, Robert, Perry, Judith, Bedford, Philip, Brown, David, Chatfield, Stephen, Dougan, Gordon, Levine, Myron M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2000
Gaiak:
Microbial Immunity and Vaccines
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC97267/
https://ncbi.nlm.nih.gov/pubmed/10678926
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak